Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation

Špela Zupančič, Petra Kocbek, M Gulrez Zariwala, Derek Renshaw, Mine Orlu Gul, Zeeneh Elsaid, Kevin M G Taylor, Satyanarayana Somavarapu

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Curcumin has potent antioxidant and anti-inflammatory properties but poor absorption following oral administration owing to its low aqueous solubility. Development of novel formulations to improve its in vivo efficacy is therefore challenging. In this study, formulation of curcumin-loaded DQAsomes (vesicles formed from the amphiphile, dequalinium) for pulmonary delivery is presented for the first time. The vesicles demonstrated mean hydrodynamic diameters between 170 and 200 nm, with a ζ potential of approximately +50 mV, high drug loading (up to 61%) and encapsulation efficiency (90%), resulting in enhanced curcumin aqueous solubility. Curcumin encapsulation in DQAsomes in the amorphous state was confirmed by X-ray diffraction and differential scanning calorimetry analysis. The existence of hydrogen bonds and cation-π interaction between curcumin and vesicle building blocks, namely dequalinium molecules, were shown in lyophilized DQAsomes using FT-IR analysis. Encapsulation of curcumin in DQAsomes enhanced the antioxidant activity of curcumin compared to free curcumin. DQAsome dispersion was successfully nebulized with the majority of the delivered dose deposited in the second stage of the twin-stage impinger. The vesicles showed potential for mitochondrial targeting. Curcumin-loaded DQAsomes thus represent a promising inhalation formulation with improved stability characteristics and mitochondrial targeting ability, indicating a novel approach for efficient curcumin delivery for effective treatment of acute lung injury and the rationale for future in vivo studies.

Original languageEnglish
Pages (from-to)2334-2345
Number of pages12
JournalScientia Pharmaceutica
Volume11
Issue number7
Early online date22 May 2014
DOIs
Publication statusPublished - 7 Jul 2014

Fingerprint

Curcumin
Inhalation
Dequalinium
Solubility
Antioxidants
Acute Lung Injury
Differential Scanning Calorimetry
Hydrodynamics
X-Ray Diffraction
Oral Administration
Cations
Hydrogen
Anti-Inflammatory Agents
Lung

Keywords

  • Administration, Inhalation
  • Chemistry, Pharmaceutical
  • Curcumin
  • Dequalinium
  • Drug Carriers
  • Drug Delivery Systems
  • Mitochondria
  • Nanoparticles
  • Particle Size
  • Solubility
  • X-Ray Diffraction
  • Journal Article

Cite this

Zupančič, Š., Kocbek, P., Zariwala, M. G., Renshaw, D., Gul, M. O., Elsaid, Z., ... Somavarapu, S. (2014). Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation. Scientia Pharmaceutica, 11(7), 2334-2345. https://doi.org/10.1021/mp500003q

Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation. / Zupančič, Špela; Kocbek, Petra; Zariwala, M Gulrez; Renshaw, Derek; Gul, Mine Orlu; Elsaid, Zeeneh; Taylor, Kevin M G; Somavarapu, Satyanarayana.

In: Scientia Pharmaceutica, Vol. 11, No. 7, 07.07.2014, p. 2334-2345.

Research output: Contribution to journalArticle

Zupančič, Š, Kocbek, P, Zariwala, MG, Renshaw, D, Gul, MO, Elsaid, Z, Taylor, KMG & Somavarapu, S 2014, 'Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation' Scientia Pharmaceutica, vol. 11, no. 7, pp. 2334-2345. https://doi.org/10.1021/mp500003q
Zupančič, Špela ; Kocbek, Petra ; Zariwala, M Gulrez ; Renshaw, Derek ; Gul, Mine Orlu ; Elsaid, Zeeneh ; Taylor, Kevin M G ; Somavarapu, Satyanarayana. / Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation. In: Scientia Pharmaceutica. 2014 ; Vol. 11, No. 7. pp. 2334-2345.
@article{1185d4811c3746d9b580ec1b1fc7740b,
title = "Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation",
abstract = "Curcumin has potent antioxidant and anti-inflammatory properties but poor absorption following oral administration owing to its low aqueous solubility. Development of novel formulations to improve its in vivo efficacy is therefore challenging. In this study, formulation of curcumin-loaded DQAsomes (vesicles formed from the amphiphile, dequalinium) for pulmonary delivery is presented for the first time. The vesicles demonstrated mean hydrodynamic diameters between 170 and 200 nm, with a ζ potential of approximately +50 mV, high drug loading (up to 61{\%}) and encapsulation efficiency (90{\%}), resulting in enhanced curcumin aqueous solubility. Curcumin encapsulation in DQAsomes in the amorphous state was confirmed by X-ray diffraction and differential scanning calorimetry analysis. The existence of hydrogen bonds and cation-π interaction between curcumin and vesicle building blocks, namely dequalinium molecules, were shown in lyophilized DQAsomes using FT-IR analysis. Encapsulation of curcumin in DQAsomes enhanced the antioxidant activity of curcumin compared to free curcumin. DQAsome dispersion was successfully nebulized with the majority of the delivered dose deposited in the second stage of the twin-stage impinger. The vesicles showed potential for mitochondrial targeting. Curcumin-loaded DQAsomes thus represent a promising inhalation formulation with improved stability characteristics and mitochondrial targeting ability, indicating a novel approach for efficient curcumin delivery for effective treatment of acute lung injury and the rationale for future in vivo studies.",
keywords = "Administration, Inhalation, Chemistry, Pharmaceutical, Curcumin, Dequalinium, Drug Carriers, Drug Delivery Systems, Mitochondria, Nanoparticles, Particle Size, Solubility, X-Ray Diffraction, Journal Article",
author = "Špela Zupančič and Petra Kocbek and Zariwala, {M Gulrez} and Derek Renshaw and Gul, {Mine Orlu} and Zeeneh Elsaid and Taylor, {Kevin M G} and Satyanarayana Somavarapu",
year = "2014",
month = "7",
day = "7",
doi = "10.1021/mp500003q",
language = "English",
volume = "11",
pages = "2334--2345",
journal = "Scientia Pharmaceutica",
issn = "0036-8709",
publisher = "{\"O}sterreichischer Apothekerverlag",
number = "7",

}

TY - JOUR

T1 - Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation

AU - Zupančič, Špela

AU - Kocbek, Petra

AU - Zariwala, M Gulrez

AU - Renshaw, Derek

AU - Gul, Mine Orlu

AU - Elsaid, Zeeneh

AU - Taylor, Kevin M G

AU - Somavarapu, Satyanarayana

PY - 2014/7/7

Y1 - 2014/7/7

N2 - Curcumin has potent antioxidant and anti-inflammatory properties but poor absorption following oral administration owing to its low aqueous solubility. Development of novel formulations to improve its in vivo efficacy is therefore challenging. In this study, formulation of curcumin-loaded DQAsomes (vesicles formed from the amphiphile, dequalinium) for pulmonary delivery is presented for the first time. The vesicles demonstrated mean hydrodynamic diameters between 170 and 200 nm, with a ζ potential of approximately +50 mV, high drug loading (up to 61%) and encapsulation efficiency (90%), resulting in enhanced curcumin aqueous solubility. Curcumin encapsulation in DQAsomes in the amorphous state was confirmed by X-ray diffraction and differential scanning calorimetry analysis. The existence of hydrogen bonds and cation-π interaction between curcumin and vesicle building blocks, namely dequalinium molecules, were shown in lyophilized DQAsomes using FT-IR analysis. Encapsulation of curcumin in DQAsomes enhanced the antioxidant activity of curcumin compared to free curcumin. DQAsome dispersion was successfully nebulized with the majority of the delivered dose deposited in the second stage of the twin-stage impinger. The vesicles showed potential for mitochondrial targeting. Curcumin-loaded DQAsomes thus represent a promising inhalation formulation with improved stability characteristics and mitochondrial targeting ability, indicating a novel approach for efficient curcumin delivery for effective treatment of acute lung injury and the rationale for future in vivo studies.

AB - Curcumin has potent antioxidant and anti-inflammatory properties but poor absorption following oral administration owing to its low aqueous solubility. Development of novel formulations to improve its in vivo efficacy is therefore challenging. In this study, formulation of curcumin-loaded DQAsomes (vesicles formed from the amphiphile, dequalinium) for pulmonary delivery is presented for the first time. The vesicles demonstrated mean hydrodynamic diameters between 170 and 200 nm, with a ζ potential of approximately +50 mV, high drug loading (up to 61%) and encapsulation efficiency (90%), resulting in enhanced curcumin aqueous solubility. Curcumin encapsulation in DQAsomes in the amorphous state was confirmed by X-ray diffraction and differential scanning calorimetry analysis. The existence of hydrogen bonds and cation-π interaction between curcumin and vesicle building blocks, namely dequalinium molecules, were shown in lyophilized DQAsomes using FT-IR analysis. Encapsulation of curcumin in DQAsomes enhanced the antioxidant activity of curcumin compared to free curcumin. DQAsome dispersion was successfully nebulized with the majority of the delivered dose deposited in the second stage of the twin-stage impinger. The vesicles showed potential for mitochondrial targeting. Curcumin-loaded DQAsomes thus represent a promising inhalation formulation with improved stability characteristics and mitochondrial targeting ability, indicating a novel approach for efficient curcumin delivery for effective treatment of acute lung injury and the rationale for future in vivo studies.

KW - Administration, Inhalation

KW - Chemistry, Pharmaceutical

KW - Curcumin

KW - Dequalinium

KW - Drug Carriers

KW - Drug Delivery Systems

KW - Mitochondria

KW - Nanoparticles

KW - Particle Size

KW - Solubility

KW - X-Ray Diffraction

KW - Journal Article

U2 - 10.1021/mp500003q

DO - 10.1021/mp500003q

M3 - Article

VL - 11

SP - 2334

EP - 2345

JO - Scientia Pharmaceutica

JF - Scientia Pharmaceutica

SN - 0036-8709

IS - 7

ER -